ArticleClinical & translational immunology2024

Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of gender: results from the SINUS-52 trial.

Wytske J Fokkens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.